PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
PRDS
Delisted
PRDS was delisted on the 30th of August, 2023.
65 hedge funds and large institutions have $63.8M invested in Pardes Biosciences, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
27% less capital invested
Capital invested by funds: $87.2M → $63.8M (-$23.4M)
Holders
65
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$2.11M | |
| 2 | +$1.23M | |
| 3 | +$1.08M | |
| 4 |
Walleye Capital
New York
|
+$451K |
| 5 |
C
Chescapmanager
Baltimore,
Maryland
|
+$250K |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$6.16M | |
| 3 | -$1.56M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.4M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$788K |